Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from 2seventy bio

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

Bristol Myers Squibb (NYSE:BMY) and 2seventy bio (NASDAQ:TSVT) announced positive topline results from KarMMa-3, a Phase 3 study evaluating Abecma (idecabtagene vicleucel) compared to standard combination regimens in adults with multiple myeloma that is relapsed and refractory. Bristol Myers shares traded in a range of $73.95 to $75.32 on a day volume…

Benzinga · Aug 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022

Upgrades

Benzinga · May 2, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Israel

51,201 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.